Poly(N-vinylcaprolactam) Nanogels with Antiviral Behavior against HIV-1 Infection.
Sci Rep
; 9(1): 5732, 2019 04 05.
Article
in En
| MEDLINE
| ID: mdl-30952921
ABSTRACT
Stimuli-responsive nanogels offer promising perspectives for the development of next generation formulations for biomedical applications. In this work, poly(N-vinylcaprolactam) nanogels were synthesized varying the concentration of monomer and crosslinking agent. Thus, the inhibitory effect of poly(N-vinylcaprolactam) nanogels against HIV-1 infection is presented for the first time. In particular, we have demonstrated that one of the synthesized poly(N-vinylcaprolactam) nanogels with initial concentration of 80 mg of vinylcaprolactam and 4% of crosslinking agent shows antiviral behavior against HIV-1 infection since this nanogel inhibits the viral replication in TZM.bl target cells.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Polymers
/
Virus Replication
/
Caprolactam
/
Cell Survival
/
HIV-1
/
Nanogels
Language:
En
Journal:
Sci Rep
Year:
2019
Document type:
Article
Affiliation country:
Argentina